期刊文献+

血管紧张素Ⅱ和NADPH氧化酶与血管衰老的相关性研究 被引量:9

Study on the relationship between angiotensinⅡ and NADPH oxidase and vascular aging
下载PDF
导出
摘要 目的探讨血管紧张素Ⅱ(AngⅡ)和NADPH氧化酶在血管衰老中的地位及作用机理。方法健康W istar大鼠分为青年组、老龄组、Valsantan组,分析各组大鼠主动脉形态结构及功能;测定血浆和主动脉AngⅡ水平、主动脉活性氧水平;分别应用RT-PCR和W estern bolt检测各组大鼠AngⅡ1型和2型受体(AT1R和AT2R)、NADPH氧化酶p22phox的mRNA及蛋白表达。结果随增龄大鼠主动脉管壁增厚,纤维化程度增高,内皮功能受损,活性氧产生增加;主动脉AngⅡ含量增高,AT2R、p22phox的mRNA及蛋白表达上调,AT1R表达下降;Valsantan(AngⅡ1型受体特异性阻断剂)干预后,p22phox表达下降,活性氧水平降低,衰老血管形态结构和功能异常有所改善。结论衰老血管有其特征性结构和功能改变;AngⅡ经由AT1R上调NADPH氧化酶的基因表达可能是血管衰老的重要机制之一。 Objective To explore the role of angiotensin (Ang) Ⅱ and NADPH oxidase in vascular aging and its action mechanism. Methods The healthy rats were divided into young group, aging group and valsartan group to analyze aorta structure and function, and to detect Ang Ⅱ level in plasma and aorta, and reactive oxygen species (ROS). RT-PCR and Western blot were used to analyze mRNA and protein expression of NADPH oxidase p22phox, Ang Ⅱ type 1 and 2 receptor (AT1R, AT2R). Results With aging, aorta wall thickened, fibrosis degree increased, endothelial function were damaged, ROS production enhanced; the level of Ang Ⅱ increased in aorta, mRNA and protein expression of p22phox and AT2R increased, but the expression of AT1 R attenuated. The expression of p22phox and ROS decreased, aorta structural and functional changes were alleviated after treated by valsartan. Conclusions Vascular aging has its specific structure and function changes ; Ang Ⅱ up-regulating the gene expression of NADPH oxidase via AT1R might be one of mechanisms of vascular aging.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2006年第4期493-496,共4页 Chinese Journal of Gerontology
基金 国家重点基础研究发展规划项目资助(课题号:G2000057006)
关键词 血管衰老 血管紧张素Ⅱ NADPH氧化酶 活性氧 VALSARTAN Vascular aging Angiotensin Ⅱ NADPH oxidase Reactive oxygen species Valsartan
  • 相关文献

参考文献14

  • 1李虹,白小涓,陈香美.血管衰老机理及检测指标的研究进展[J].中华医学杂志,2005,85(3):212-215. 被引量:31
  • 2Lakatta EG,Levy D.Arterial and cardiac aging:major shareholders in cardiovascular disease enterprises part Ⅰ:aging arteries:a" set up" for vascular disease[J].Circulation,2003; 107:139-46.
  • 3Minamino T,Miyauchi H,Yoshida T,et al.Endothelial cell senescence in human atherosclerosis; role of telomere in endothelial dysfunction[J].Circulation,2002; 105:1541-4.
  • 4Michel J B,Heudes,D,Michel O.Effect of chronic ANG Ⅰ-converting enzyme inhibition on aging processes.Ⅱ.Large arteries[J].Am J Physiol,1994 ;267:124-5.
  • 5白小涓,李虹,杨莹,刘宇翔,陈香美.洛沙坦对心脏和动脉衰老保护作用的实验研究[J].中国老年学杂志,2005,25(2):171-173. 被引量:3
  • 6Zhang CX,Yang J,Jennings LK.Leukocyte-derived myeloperoxidase amplifies high glucose induced endothelial dysfunction through interaction with high-glucose-stimulated vascular non-leukocyte-derived reactive oxygen species[J].Diabetes,2004 ;53 ;2950-9.
  • 7Neuman RE,Logan MA.The determination of collagen and elastin in tissues[J].J Biol Chem,1950; 184:549 -56.
  • 8Xu JW,Katsumi IKEDA,Yamori Y.Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin Ⅱ Type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive Rats[J].Hypertens Res,2004 ;27:675-83.
  • 9陈样新,傅国胜.血管紧张素Ⅱ及其受体与血管内皮功能的关系[J].临床心血管病杂志,2003,19(11):698-700. 被引量:28
  • 10Tarpey MM,Fridovich Ⅰ.Methods of detection of vascular reactive speciesNitric oxide,superoxide,hydrogen peroxide,and peroxynitrite[J].Circ Res,2001 ;89:224-36.

二级参考文献60

  • 1Ruschitzka F T,Nall G, Lascher T F. The endothellum in coronary artery disease. Cardiology, 1997,88 : 3-- 19.
  • 2Rajagopalan S, Harrison D G. Reversing endothelial dysfuntion with ACE inhibitors: A new TREND? Circulation, 1996, 94:240--243.
  • 3Rajagopalan S, Kurz S, Munzcl T, et al. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alternation of vasomotor tone. J Clin Invest, 1996,97 : 1916-- 1923.
  • 4Harrison D G. Endothelial control of vasomotion and nitric oxide production. Cardiol Clin, 1996,14 : 1-- 15.
  • 5Warnholtz A, Nickenig G, Schulz E, et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis:evidence for the involvement of the rennin-angiotensin system. Circulation,1999, 99:2027--2033.
  • 6Vaughan D E. Fibrinolytic balance, the rennin-angiotensin system and atherosclerotic disease. Eur Heart J,1998,19 : G9-- G12.
  • 7Nishimura H, Tsuji H. The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial calls. Thromb Haemostasis, 1999,82:1516--1521.
  • 8Morawietz H, Rueckschloss U. Angiotensin II induces LOX- 1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation, 1999, 100:899 --902.
  • 9Goodfield M B, Newby D E. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. Circulation, 1999,99:2983--2985.
  • 10Brown N J, Agirbasli M, Vaughan D E. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans. Hypertension, 1999,34:285--290.

共引文献58

同被引文献111

引证文献9

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部